JP2000509399A5 - - Google Patents

Download PDF

Info

Publication number
JP2000509399A5
JP2000509399A5 JP1997539353A JP53935397A JP2000509399A5 JP 2000509399 A5 JP2000509399 A5 JP 2000509399A5 JP 1997539353 A JP1997539353 A JP 1997539353A JP 53935397 A JP53935397 A JP 53935397A JP 2000509399 A5 JP2000509399 A5 JP 2000509399A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997539353A
Other languages
English (en)
Japanese (ja)
Other versions
JP4624498B2 (ja
JP2000509399A (ja
Filing date
Publication date
Priority claimed from AUPN9697A external-priority patent/AUPN969796A0/en
Application filed filed Critical
Publication of JP2000509399A publication Critical patent/JP2000509399A/ja
Publication of JP2000509399A5 publication Critical patent/JP2000509399A5/ja
Application granted granted Critical
Publication of JP4624498B2 publication Critical patent/JP4624498B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP53935397A 1996-05-07 1997-05-07 味隠蔽された懸濁液 Expired - Fee Related JP4624498B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPN9697A AUPN969796A0 (en) 1996-05-07 1996-05-07 Taste masked liquid suspensions
AU9697 1996-05-07
PCT/AU1997/000279 WO1997041839A1 (en) 1996-05-07 1997-05-07 Taste masked liquid suspensions

Publications (3)

Publication Number Publication Date
JP2000509399A JP2000509399A (ja) 2000-07-25
JP2000509399A5 true JP2000509399A5 (cg-RX-API-DMAC7.html) 2005-01-13
JP4624498B2 JP4624498B2 (ja) 2011-02-02

Family

ID=3794010

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53935397A Expired - Fee Related JP4624498B2 (ja) 1996-05-07 1997-05-07 味隠蔽された懸濁液

Country Status (11)

Country Link
US (1) US6197348B1 (cg-RX-API-DMAC7.html)
EP (1) EP0921789B1 (cg-RX-API-DMAC7.html)
JP (1) JP4624498B2 (cg-RX-API-DMAC7.html)
AT (1) ATE258432T1 (cg-RX-API-DMAC7.html)
AU (1) AUPN969796A0 (cg-RX-API-DMAC7.html)
CA (1) CA2253811C (cg-RX-API-DMAC7.html)
DE (1) DE69727386T2 (cg-RX-API-DMAC7.html)
DK (1) DK0921789T3 (cg-RX-API-DMAC7.html)
ES (1) ES2215223T3 (cg-RX-API-DMAC7.html)
PT (1) PT921789E (cg-RX-API-DMAC7.html)
WO (1) WO1997041839A1 (cg-RX-API-DMAC7.html)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754177B1 (fr) * 1996-10-07 1999-08-06 Sanofi Sa Microspheres pharmaceutiques d'acide valproique pour administration orale
DE19809719A1 (de) * 1998-03-06 1999-09-09 Roehm Gmbh Wäßrige Dispersion geeignet zur Herstellung von Überzugs- und Bindemitteln für feste orale Arzneiformen
DE19845358A1 (de) * 1998-10-02 2000-04-06 Roehm Gmbh Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
WO2000045793A1 (en) * 1999-02-04 2000-08-10 Abbott Laboratories Ph independent extended release pharmaceutical formulation
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
CA2395993A1 (en) * 1999-12-28 2001-07-05 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
KR20030047873A (ko) * 2000-02-29 2003-06-18 테바 파마슈티컬 인더스트리즈 리미티드 클라리트로마이신 및 클라리트로마이신 중간체의 제조방법, 실질적으로는 옥심이 제거된 클라리트로마이신 및이를 포함하는 약학적 조성물
FR2826274B1 (fr) * 2001-06-21 2003-09-26 Aventis Pharma Sa Formulation pharmaceutique au gout masque et son procede de preparation
KR100664822B1 (ko) 2002-02-01 2007-01-04 화이자 프로덕츠 인코포레이티드 변형된 분무-건조 장치를 이용한 균질한 분무-건조된 고체비결정성 약물 분산액의 제조 방법
EP1482789A4 (en) * 2002-03-12 2010-12-29 Toyama Chemical Company Ltd TASTY ORAL SUSPENSION AND METHOD
US6930119B2 (en) * 2002-07-17 2005-08-16 Reliant Pharmaceuticals, Inc. Liquid pharmaceutical composition
HUE038446T2 (hu) * 2002-09-20 2018-10-29 Alpharma Pharmaceuticals Llc Szekvesztráló alegység és releváns kompozíciók és módszerek
US20040091544A1 (en) * 2002-11-08 2004-05-13 Ruff Michael D. Coated dibasic calcium phosphate
US20040170686A1 (en) * 2003-01-31 2004-09-02 Fredrickson Jennifer K. Suspension vehicle for coated drug particles
US20040186180A1 (en) 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
US20040191326A1 (en) * 2003-03-31 2004-09-30 Reo Joseph P. Taste-masking vehicle for coated oxazolidinone particles
US7520489B2 (en) * 2003-06-17 2009-04-21 Filtertek Inc. Fluid handling device and method of making same
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
US20050163843A1 (en) * 2003-12-31 2005-07-28 Garth Boehm Alprazolam formulations
ES2390879T3 (es) * 2003-12-31 2012-11-19 Actavis Group Ptc Ehf. Formulaciones de atomoxetina
WO2005065660A2 (en) * 2003-12-31 2005-07-21 Alpharma, Inc. Ziprasidone formulations
WO2005065663A1 (en) * 2003-12-31 2005-07-21 Alpharma, Inc. Rosiglitazone and metformin formulations
EP1732513A2 (en) * 2003-12-31 2006-12-20 Alpharma, Inc. Rosiglitazone formulations
WO2005065645A2 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Donepezil formulations
US20050191349A1 (en) * 2003-12-31 2005-09-01 Garth Boehm Galantamine formulations
US20050142193A1 (en) * 2003-12-31 2005-06-30 Lijuan Tang Galantamine formulations
BRPI0514753A (pt) * 2004-08-31 2008-06-24 Pfizer Prod Inc formas de dosagem farmacêutica compreendendo um medicamento de baixa solubilidade e um polìmero
GB2419094A (en) * 2004-10-12 2006-04-19 Sandoz Ag Pharmaceutical composition of unpleasnt tasing active substances
US7378109B2 (en) * 2004-12-23 2008-05-27 Council Of Scientific And Industrial Research Pharmaceutical composition for improving palatability of drugs and process for preparation thereof
WO2006093784A2 (en) * 2005-02-25 2006-09-08 Mutual Pharmaceutical Company, Inc. Dosage forms of antibiotics and combinations of antibiotics ans symptomatic relief agents
US20060264458A1 (en) * 2005-05-03 2006-11-23 Jie Du Quinine dosage forms and methods of use thereof
CN1883456B (zh) * 2005-06-20 2010-12-15 常州市第四制药厂有限公司 掩味药物颗粒及其制备方法和用途
JP2007031407A (ja) * 2005-07-29 2007-02-08 Shin Etsu Chem Co Ltd 低置換度セルロースエーテル含有コーティング用組成物及び不快な味が隠蔽されたフィルムコーティング製剤
US20070087056A1 (en) * 2005-08-09 2007-04-19 Claudia Guthmann Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
ATE486593T1 (de) * 2006-03-16 2010-11-15 Novartis Ag Feste dosierungsform mit einem wirkstoff mit unterdrücktem geschmack
JP4892264B2 (ja) * 2006-03-30 2012-03-07 高田製薬株式会社 リスペリドン水性液剤
DK2526932T3 (en) 2006-06-19 2017-07-17 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US7915247B1 (en) 2006-08-21 2011-03-29 Mutual Pharmaceutical Company, Inc. Methods of use of fenofibric acid
JP2010506833A (ja) * 2006-10-11 2010-03-04 アルファーマ,インコーポレイテッド 医薬組成物
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
WO2008065502A1 (en) * 2006-11-29 2008-06-05 Pfizer Products Inc. Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein
KR20090094319A (ko) * 2006-12-26 2009-09-04 시오노기 앤드 컴파니, 리미티드 리스페리돈을 함유하는 구강내붕괴 정제 및 고미억제 제제
JP4941977B2 (ja) * 2007-04-11 2012-05-30 大蔵製薬株式会社 ベンズイソキサゾール誘導体の経口ゼリー状医薬組成物
US20100119612A1 (en) * 2007-04-17 2010-05-13 Bend Research, Inc Nanoparticles comprising non-crystalline drug
WO2008135828A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
US20100080852A1 (en) * 2007-05-03 2010-04-01 Ronald Arthur Beyerinck Phamaceutical composition comprising nanoparticles and casein
WO2008135855A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
WO2008149192A2 (en) * 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
EP2178518A2 (en) * 2007-07-13 2010-04-28 Bend Research, Inc Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
WO2009073215A1 (en) * 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
US9233078B2 (en) * 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
AU2008346870A1 (en) * 2007-12-17 2009-07-16 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
KR101294648B1 (ko) 2009-03-27 2013-08-09 도레이 카부시키가이샤 피복 고형제제
US20110150986A1 (en) * 2009-12-18 2011-06-23 Kristin Arnold Quinine formulations, method of making, and metho of use thereof
MX339408B (es) * 2010-03-09 2016-05-24 Alkermes Pharma Ireland Ltd Composiciones farmaceuticas entericas resistentes al alcohol.
US11957792B2 (en) 2012-04-19 2024-04-16 Glatt Ag Taste-masked pharmaceutical compositions containing diclofenac
US10835495B2 (en) 2012-11-14 2020-11-17 W. R. Grace & Co.-Conn. Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same
WO2017057884A1 (ko) * 2015-09-30 2017-04-06 (주)아모레퍼시픽 자가회복 가능한 코어-쉘 캡슐
US9463183B1 (en) * 2015-10-30 2016-10-11 Silvergate Pharmaceuticals, Inc. Lisinopril formulations
WO2020011938A1 (en) 2018-07-11 2020-01-16 Medizinische Universität Wien Glucocorticoids for the topical treatment of autoimmune gastritis
CN113181133A (zh) * 2021-04-25 2021-07-30 海南通用三洋药业有限公司 一种罗红霉素胶囊的制备方法
CN116687843A (zh) * 2022-12-16 2023-09-05 中国人民解放军军事科学院军事医学研究院 一种高稳定性的布瓦西坦溶液及其制备方法和其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US5286489A (en) * 1985-08-26 1994-02-15 The Procter & Gamble Company Taste masking compositions
JPS63150220A (ja) * 1986-12-15 1988-06-22 Dainippon Pharmaceut Co Ltd 経口用固形製剤の製造方法
JPS63218247A (ja) * 1987-03-06 1988-09-12 Yoshiaki Kawashima 高機能懸濁液
DE58903964D1 (de) * 1988-11-10 1993-05-06 Ciba Geigy Ag Fluessige orale formulierung.
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
IT1246383B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per il mascheramento del sapore di farmaci
CA2085342A1 (en) 1990-06-14 1991-12-15 Milton R. Kaplan Stable aqueous drug suspensions
GB9015822D0 (en) * 1990-07-18 1990-09-05 Beecham Group Plc Compositions
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
JP3265680B2 (ja) * 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物
CA2137265C (en) * 1992-06-04 2003-10-28 Sanjay Bhardwaj Palatable pharmaceutical compositions
AU6774694A (en) * 1993-04-26 1994-11-21 Affinity Biotech, Inc. Taste-masking pharmaceutical compositions and methods for making the same
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids

Similar Documents

Publication Publication Date Title
JP2001507295A5 (cg-RX-API-DMAC7.html)
JP2001507384A5 (cg-RX-API-DMAC7.html)
JP2001502505A5 (cg-RX-API-DMAC7.html)
JP2000506916A5 (cg-RX-API-DMAC7.html)
JP2001502493A5 (cg-RX-API-DMAC7.html)
JP2001506384A5 (cg-RX-API-DMAC7.html)
JP2000515006A5 (cg-RX-API-DMAC7.html)
JP2000516761A5 (cg-RX-API-DMAC7.html)
JP2000508477A5 (cg-RX-API-DMAC7.html)
JP2000510124A5 (cg-RX-API-DMAC7.html)
JP2001503506A5 (cg-RX-API-DMAC7.html)
JP2001502734A5 (cg-RX-API-DMAC7.html)
JP2001505191A5 (cg-RX-API-DMAC7.html)
JP2000509399A5 (cg-RX-API-DMAC7.html)
JP2000512184A5 (cg-RX-API-DMAC7.html)
JP2000512107A5 (cg-RX-API-DMAC7.html)
JP2000516162A5 (cg-RX-API-DMAC7.html)
JP2001507029A5 (cg-RX-API-DMAC7.html)
JP2000505352A5 (cg-RX-API-DMAC7.html)
JP2001507002A5 (cg-RX-API-DMAC7.html)
JP2001507792A5 (cg-RX-API-DMAC7.html)
JP2000502931A5 (cg-RX-API-DMAC7.html)
JP2001506915A5 (cg-RX-API-DMAC7.html)
JP2001502609A5 (cg-RX-API-DMAC7.html)
JP2001505234A5 (cg-RX-API-DMAC7.html)